To evaluate in vitro secretion of FGF, PDGF, VEGF, and GM-CSF by PBMCs from women with confirmed endometriosis and matched controls.
Key Findings:
No significant difference in baseline secretion of FGF, PDGF, VEGF, and GM-CSF between women with endometriosis and controls after correction for multiple comparisons.
PHA stimulation increased FGF, PDGF, and VEGF, but no significant differences were observed between groups after adjustment.
Univariate logistic regression found no baseline growth-factor measures significantly predicted endometriosis presence.
Interpretation:
The study indicates that PBMCs from women with endometriosis do not show increased secretion of the evaluated growth factors compared to controls, suggesting a localized model of pro-angiogenic signaling.
Limitations:
The study's findings are based on in vitro conditions and may not fully represent in vivo dynamics, limiting the applicability of results.
The relatively small sample size may restrict the generalizability of the findings.
Conclusion:
The data do not support systemic PBMC hypersecretion of FGF, PDGF, VEGF, and GM-CSF in endometriosis.
